WatlingSMJohnsonMYanosJ. A method to produce sedation in critically ill patients. Ann Pharmacother1996; 30: 1227–31.
2.
Van de WieleBRubinsteinEPeacockWMartinN. Propylene glycol toxicity caused by prolonged infusion of etomidate. J Neurosurg Anesthesiol1995; 7: 259–62.
3.
LevyMLArandaMZelmanVGiannottaSL. Propylene glycol toxicity following continuous etomidate infusion for the control of refractory cerebral edema. Neurosurgery1995; 37: 363–9.
4.
BedichekEKirschbaumB. A case of propylene glycol toxic reaction associated with etomidate infusion. Arch Intern Med1991; 151: 2297–8.
5.
DemeyHEDaelemansRAVerpootenGABroeMEVan CampenhoutCMLakiereFV. Propylene glycol-induced side effects during intravenous nitroglycerin therapy. Intens Care Med1988; 14: 221–6.
6.
FlignerCLJackRTwiggsGARaisysVA. Hyperosmolality induced by propylene glycol. A complication of silver sulfadiazine therapy. JAMA1985; 253: 1606–9.
7.
KulickMILewisNSBansalVWarpehaR. Hyperosmolality in the burn patient: Analysis of an osmolal discrepancy. J Trauma1980; 20: 223–8.
8.
BekerisLBakerCFentonJKimballDBermesE. Propylene glycol as a cause of an elevated serum osmolality. Am J Clin Pathol1979; 72: 633–6.
9.
Package insert.Ativan injection (lorazepam). Philadelphia: Wyeth-Ayerst Laboratories, February 1995.
10.
Package insert.Diazepam injection. Cherry Hill, NJ: Elkins-Sinn, October 1994.